595 related articles for article (PubMed ID: 29996830)
1. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
Luo H; Fan Q; Xiao S; Chen K
BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
[TBL] [Abstract][Full Text] [Related]
2. Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
Zeng W; Finlayson AE; Shankar S; de Bruyn W; Godman B
BMC Health Serv Res; 2015 Jan; 15():11. PubMed ID: 25609265
[TBL] [Abstract][Full Text] [Related]
3. Evolution of proton pump inhibitor prescribing from 2017 to 2021 at 14 secondary and tertiary hospitals in China：a multicentre cross-sectional study.
Zeng M; Li Y; Chen T; Zhang S; Luo H
BMJ Open; 2023 Jul; 13(7):e072793. PubMed ID: 37400237
[TBL] [Abstract][Full Text] [Related]
4. Trends in prescribing proton pump inhibitors in Taiwan: 1997 - 2000.
Chen TJ; Chou LF; Hwang SJ
Int J Clin Pharmacol Ther; 2003 May; 41(5):207-12. PubMed ID: 12776811
[TBL] [Abstract][Full Text] [Related]
5. Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.
McGinn D; Godman B; Lonsdale J; Way R; Wettermark B; Haycox A
Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):73-85. PubMed ID: 20121565
[TBL] [Abstract][Full Text] [Related]
6. Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China.
Luo H; Fan Q; Bian T; Li X; Chen K; Zhang Q; Wei Y; Xiao Y; Li Y
BMC Health Serv Res; 2019 Nov; 19(1):880. PubMed ID: 31752835
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors: a study of GPs' prescribing.
Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
[TBL] [Abstract][Full Text] [Related]
8. The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
Fraeyman J; Van Hal G; Godman B; Beutels P
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):141-51. PubMed ID: 23402454
[TBL] [Abstract][Full Text] [Related]
9. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
[TBL] [Abstract][Full Text] [Related]
10. Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice.
Bundeff AW; Zaiken K
J Manag Care Pharm; 2013 May; 19(4):325-33. PubMed ID: 23627578
[TBL] [Abstract][Full Text] [Related]
11. Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010-2018.
Rückert-Eheberg IM; Nolde M; Ahn N; Tauscher M; Gerlach R; Güntner F; Günter A; Meisinger C; Linseisen J; Amann U; Baumeister SE
Eur J Clin Pharmacol; 2022 Apr; 78(4):657-667. PubMed ID: 34877614
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
[TBL] [Abstract][Full Text] [Related]
13. Rationale use of proton pump inhibitors: Observational study of hospital based prescriptions and role of clinical pharmacist.
Afshan A
Pak J Pharm Sci; 2018 Jul; 31(4):1217-1227. PubMed ID: 30033404
[TBL] [Abstract][Full Text] [Related]
14. Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments.
Liu L; Yu Y; Fan Q; Wu Z; Li X; Luo H
BMC Health Serv Res; 2022 Mar; 22(1):417. PubMed ID: 35351121
[TBL] [Abstract][Full Text] [Related]
15. General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
Haastrup PF; Rasmussen S; Hansen JM; Christensen RD; Søndergaard J; Jarbøl DE
BMC Fam Pract; 2016 May; 17():57. PubMed ID: 27233634
[TBL] [Abstract][Full Text] [Related]
16. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence.
Solem C; Mody R; Stephens J; Macahilig C; Gao X
J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of proton pump inhibitors anti-ulcer drugs use in the Araba district primary care area].
Martínez Gorostiaga J; Echevarría Orella E; Calvo Hernáez B
Rev Esp Salud Publica; 2018 Aug; 92():. PubMed ID: 30100604
[TBL] [Abstract][Full Text] [Related]
18. Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland.
Bennie M; Godman B; Bishop I; Campbell S
Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):125-30. PubMed ID: 22280202
[TBL] [Abstract][Full Text] [Related]
19. Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.
Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L
BMC Fam Pract; 2020 May; 21(1):85. PubMed ID: 32386520
[TBL] [Abstract][Full Text] [Related]
20. Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital.
Ramirez E; Lei SH; Borobia AM; Piñana E; Fudio S; Muñoz R; Campos A; Carcas AJ; Frias J
Curr Clin Pharmacol; 2010 Nov; 5(4):288-97. PubMed ID: 20925644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
